Protective protein linked to longer lifespan in Parkinson's mouse model
A protein called alpha-synuclein abnormally aggregates in Parkinson's disease. Researchers found increasing levels of a protective protein suppressed this buildup and more than doubled lifespan in a mouse model.
This research may help understand Parkinson's progression and could inform future treatments, though it is based on animal studies.
Study type and model
The findings come from a lab study using a mouse model of Parkinson's disease, where alpha-synuclein aggregation is a key feature.
Protective protein effect
Researchers observed that increasing levels of the protective protein reduced toxic buildup and extended lifespan in the mice.
Common questions
What does this study suggest about Parkinson's disease?
It suggests that increasing a protective protein may reduce harmful alpha-synuclein buildup, which is linked to Parkinson's progression.
Is this research applicable to humans?
The study was conducted in mice, so its relevance to humans is not yet known and requires further research.
Sources
- Increasing protective protein suppresses Parkinson's-linked buildup, more than doubling lifespan in mouse model MedicalXpress · medicalxpress.com
Headlines and links belong to the publishers listed above. The summary above is written by The Health Brief; see how this works.
